Organogenesis Holdings (ORGO) Times Interest Earned (2016 - 2026)
Organogenesis Holdings' (ORGO) quarterly Times Interest Earned came in at $181.29 in Q1 2026, up 8663.01% year-on-year from $2.07 in Q1 2025, and up 167.6% quarter-over-quarter from -$268.17 in Q4 2025.
Organogenesis Holdings (ORGO) Times Interest Earned (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Times Interest Earned history runs 11 years deep, the most recent figure standing at $181.29 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 8663.01% year-over-year to $181.29 in Q1 2026; TTM through Mar 2026 was -$0.34, a 82.22% increase from a year earlier, with the FY2025 full-year figure at $2.24, up 2709.57% from the prior year.
- Times Interest Earned advanced to $181.29 in Q1 2026 per ORGO's latest filing, from -$268.17 in the prior quarter.
- Across five years, Times Interest Earned topped out at $181.29 in Q1 2026 and bottomed at -$268.17 in Q4 2025.
- The 5-year median for Times Interest Earned is -$0.43 (2023), against an average of -$5.82.
- Across the five-year window, Times Interest Earned sank 6620.74% in 2025 and surged 8663.01% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$2.02 in 2022, then surged by 77.86% to -$0.45 in 2023, then sank by 792.07% to -$3.99 in 2024, then sank by 6620.74% to -$268.17 in 2025, then surged by 167.6% to $181.29 in 2026.
- Per Business Quant, the three latest ORGO Times Interest Earned figures stand at $181.29 (Q1 2026), -$268.17 (Q4 2025), and $1.93 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | 181.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.29 |
| Dec 31, 2025 | -268.17 |
| Sep 30, 2025 | 1.93 |
| Jun 30, 2025 | -2.28 |
| Mar 31, 2025 | -2.12 |
| Dec 31, 2024 | -3.99 |
| Sep 30, 2024 | 1.89 |
| Jun 30, 2024 | -4.59 |
| Mar 31, 2024 | -0.51 |
| Dec 31, 2023 | -0.45 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -2.02 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | 14.05 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | 0.26 |